_version_ 1797280214251732992
author Hans C. Lee
Naresh Bumma
Joshua Richter
Madhav Dhodapkar
James E. Hoffman
Attaya Suvannasankha
Jeffrey Zonder
Mansi R. Shah
Suzanne Lentzsch
Joseph J. Maly
Jing Christine Ye
Ka Lung Wu
Michelle Deveaux
Dhruti Chokshi
Anita Boyapati
Anasuya Hazra
Karen Rodriguez Lorenc
Glenn Kroog
Yariv Houvras
Sundar Jagannath
author_facet Hans C. Lee
Naresh Bumma
Joshua Richter
Madhav Dhodapkar
James E. Hoffman
Attaya Suvannasankha
Jeffrey Zonder
Mansi R. Shah
Suzanne Lentzsch
Joseph J. Maly
Jing Christine Ye
Ka Lung Wu
Michelle Deveaux
Dhruti Chokshi
Anita Boyapati
Anasuya Hazra
Karen Rodriguez Lorenc
Glenn Kroog
Yariv Houvras
Sundar Jagannath
author_sort Hans C. Lee
collection DOAJ
first_indexed 2024-03-07T16:37:54Z
format Article
id doaj.art-ebffe14a73ae40d0a1f44b84269e2dd0
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:37:54Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-ebffe14a73ae40d0a1f44b84269e2dd02024-03-03T09:43:09ZengWileyHemaSphere2572-92412023-08-017e161006810.1097/01.HS9.0000967700.16100.68202308003-00099S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMAHans C. Lee0Naresh Bumma1Joshua Richter2Madhav Dhodapkar3James E. Hoffman4Attaya Suvannasankha5Jeffrey Zonder6Mansi R. Shah7Suzanne Lentzsch8Joseph J. Maly9Jing Christine Ye10Ka Lung Wu11Michelle Deveaux12Dhruti Chokshi13Anita Boyapati14Anasuya Hazra15Karen Rodriguez Lorenc16Glenn Kroog17Yariv Houvras18Sundar Jagannath191 The University of Texas MD Anderson Cancer Centre, Houston, TX, United States2 The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States3 Icahn School of Medicine at Mount Sinai, New York, New York, NY, United States4 Emory University School of Medicine, Atlanta, GA, United States5 University of Miami Health System, Miami, FL, United States6 Indiana University Simon Cancer Center and Roudebush VAMC, Indianapolis, IN, United States7 Karmanos Cancer Institute, Detroit, MI, United States8 Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, United States9 Columbia University Medical Center, New York, NY, United States10 Norton Cancer Institute, Louisville, KY, United States11 Universty of Michigan, Rogel Cancer Center, Ann Arbor, MI, United States12 Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerp, Belgium13 Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States13 Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States13 Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States13 Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States13 Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States13 Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States13 Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States3 Icahn School of Medicine at Mount Sinai, New York, New York, NY, United Stateshttp://journals.lww.com/10.1097/01.HS9.0000967700.16100.68
spellingShingle Hans C. Lee
Naresh Bumma
Joshua Richter
Madhav Dhodapkar
James E. Hoffman
Attaya Suvannasankha
Jeffrey Zonder
Mansi R. Shah
Suzanne Lentzsch
Joseph J. Maly
Jing Christine Ye
Ka Lung Wu
Michelle Deveaux
Dhruti Chokshi
Anita Boyapati
Anasuya Hazra
Karen Rodriguez Lorenc
Glenn Kroog
Yariv Houvras
Sundar Jagannath
S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
HemaSphere
title S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_full S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_fullStr S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_full_unstemmed S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_short S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_sort s197 linker mm1 study linvoseltamab regn5458 in patients with relapsed refractory multiple myeloma
url http://journals.lww.com/10.1097/01.HS9.0000967700.16100.68
work_keys_str_mv AT hansclee s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT nareshbumma s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT joshuarichter s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT madhavdhodapkar s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT jamesehoffman s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT attayasuvannasankha s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT jeffreyzonder s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT mansirshah s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT suzannelentzsch s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT josephjmaly s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT jingchristineye s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT kalungwu s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT michelledeveaux s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT dhrutichokshi s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT anitaboyapati s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT anasuyahazra s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT karenrodriguezlorenc s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT glennkroog s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT yarivhouvras s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma
AT sundarjagannath s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma